Journal profile · CELL & TISSUE ENGINEERING-BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Cellular Reprogramming
ISSN 2152-4971 · eISSN 2152-4998 · Mary Ann Liebert Inc. · UNITED STATES · Bimonthly · Founded 2010
Cellular Reprogramming: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.65; hybrid open access; review about 3 months (community reports); community-reported acceptance: about 75%; 29 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Cellular Reprogramming is published by Mary Ann Liebert Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pluripotent Stem Cells Research, CRISPR and Genetic Engineering and Reproductive Biology and Fertility, together about 55.7% of its articles. Its main subfields are Molecular Biology. (generated from OpenAlex topic counts and CAS ranking data)
The only peer-reviewed journal dedicated to cellular reprogramming mechanisms, technologies, and applications, a diverse and growing discipline that studies cellular identity reversal or modification. The field aims to understand how cell fate is acquired, maintained, and inherited in health, what happens when cell identity is hijacked in disease, and to harness cell fate engineering for therapeutic applications. The journal covers, but is not limited to, the different ways cellular reprogramming can be achieved experimentally, including nuclear transfer, cell fusion, or expression of defined factors. The journal is a forum for communicating basic cutting-edge discoveries in cellular reprogramming research, in addition to translational and clinical studies. The journal publishes high-quality original research papers, as well as review articles, perspectives, and commentaries spanning cellular reprogramming research and its societal impact. It creates a critical information hub aiming to solidify and foster the growth of the cellular reprogramming field.
From the journal's Aims & Scope
Research area (LetPub): CELL & TISSUE ENGINEERING-BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology29%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology15%
- Reproductive Biology and FertilityMedicine11.8%
- Animal Genetics and ReproductionBiochemistry, Genetics and Molecular Biology7.6%
- Tissue Engineering and Regenerative MedicineMedicine6.1%
- Mesenchymal stem cell researchMedicine5.8%
- Renal and related cancersBiochemistry, Genetics and Molecular Biology5.7%
- 3D Printing in Biomedical ResearchEngineering2.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Biotechnology & Applied Microbiology | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.65LetPub ·
- Impact factor (publisher)
- 2.7Publisher website ·
- 5-year impact factor (publisher)
- 1.7Publisher website ·
- CiteScore 2026-06
- 3.1LetPub ·
- SJR 2026-06
- 0.55LetPub ·
- SNIP 2026-06
- 0.35LetPub ·
- h-index
- 57LetPub ·
- h-index
- 49OpenAlex ·
- i10-index
- 378OpenAlex ·
- 2-year mean citedness
- 1.97OpenAlex ·
- Self-citation rate
- 3.7%LetPub ·
- Share of gold OA articles
- 7.41%LetPub ·
Volume
- Articles per year
- 14LetPub ·
Articles by year OpenAlex count · 747 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 12 | 0 | 1 |
| 2025 | 29 | 6 | 18 |
| 2024 | 29 | 6 | 119 |
| 2023 | 41 | 6 | 191 |
| 2022 | 40 | 6 | 221 |
| 2021 | 38 | 3 | 195 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Mary Ann Liebert Inc.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 2010
- ISSN
- 2152-4971
- Electronic ISSN
- 2152-4998
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Cellular Reprogramming
What CAS zone is Cellular Reprogramming in?
In the 2025 upgraded edition of the CAS Journal Ranking, Cellular Reprogramming is in Zone 4 of Medicine, and in Zone 4 of the minor category Biotechnology & Applied Microbiology / Cell & Tissue Engineering / Genetics & Heredity. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Cellular Reprogramming?
The latest impact factor listed by LetPub is 2.65; CiteScore 3.1, h-index 49.
How long does peer review take at Cellular Reprogramming?
Authors report an average review time of about 3 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Cellular Reprogramming?
According to LetPub and DOAJ records, Cellular Reprogramming is indexed in SCIE and Scopus.
Is Cellular Reprogramming open access, and what is the APC?
Cellular Reprogramming is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .